Zhangzhou Pientzehuang Pharmaceutical., Ltd
600436
株式のランク
#1900
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. is a Chinese company,... Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. is a Chinese company, headquartered in Zhangzhou, that specializes in the production and distribution of traditional Chinese medicines. Its offerings, predominantly sold under the renowned Pien Tze Huang brand, reach consumers both domestically within China and across international markets. Beyond its core pharmaceutical products, the company's expansive portfolio encompasses health and wellness items, beauty care products, household chemical goods, a variety of medical devices, and nutritional supplements. The firm operates as a subsidiary of Zhangzhou Jiulongjiang Group Co., Ltd.
株価
$18.20
時価総額
$10.98B
変化（1日）
-0.71%
変化（1年）
-28.52%
国
CN
取引 Zhangzhou Pientzehuang Pharmaceutical., Ltd (600436)
カテゴリー
Healthcare
Zhangzhou Pientzehuang Pharmaceutical., Ltd（600436）の配当利回りの履歴
Zhangzhou Pientzehuang Pharmaceutical., Ltd（銘柄コード: 600436）の配当利回り（TTM）は2024-12-31時点で1.64%です。
過去5年間の平均配当利回り: 0.95%
過去5年間の平均配当利回り: 0.95%
Zhangzhou Pientzehuang Pharmaceutical., Ltd（600436）の2001から2026までの配当利回りの履歴
各年末時点の配当利回り（TTM）
| 年 | 配当利回り | 変化 |
|---|---|---|
| 2026 (TTM) | 2.17% | 12.44% |
| 2025 | 1.93% | 17.68% |
| 2024 | 1.64% | 198.18% |
| 2023 | 0.55% | 30.95% |
| 2022 | 0.42% | 100.00% |
| 2021 | 0.21% | -32.26% |
| 2020 | 0.31% | -43.64% |
| 2019 | 0.55% | -1.79% |
| 2018 | 0.56% | 12.00% |
| 2017 | 0.50% | -16.67% |
| 2016 | 0.60% | 3.45% |
| 2015 | 0.58% | -57.66% |
| 2014 | 1.37% | 55.68% |
| 2013 | 0.88% | 27.54% |
| 2012 | 0.69% | -31.00% |
| 2011 | 1.00% | 31.58% |
| 2010 | 0.76% | -50.33% |
| 2009 | 1.53% | -46.32% |
| 2008 | 2.85% | 147.83% |
| 2007 | 1.15% | -50.00% |
| 2006 | 2.30% | 23.66% |
| 2005 | 1.86% | -45.13% |
| 2004 | 3.39% | 17.30% |
| 2003 | 2.89% | 75.15% |
| 2002 | 1.65% | -50.30% |
| 2001 | 3.32% | 0.00% |
類似企業または競合他社の配当利回り（TTM）
| 企業 | 配当利回り | 国 |
|---|---|---|
| 0.51% |
US
|
|
| 2.01% |
US
|
|
| 2.43% |
US
|
|
| 2.23% |
US
|
|
| 2.50% |
CH
|
